Stay updated on Cabotegravir vs TDF/FTC in Women Clinical Trial
Sign up to get notified when there's something new on the Cabotegravir vs TDF/FTC in Women Clinical Trial page.

Latest updates to the Cabotegravir vs TDF/FTC in Women Clinical Trial page
- Check3 days agoChange DetectedAdded a site-wide notice about a lapse in government funding that may affect data updates and updated the page version from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check10 days agoChange DetectedShow glossary option added and footer/metadata labels updated (Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, Revision: v3.4.0) replacing older labels (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4). No changes to the core study content or user-facing study details; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check46 days agoChange DetectedAdded a consolidated Locations section listing study sites (South-East District, Nyanza, Central Region, Gauteng, KwaZulu-Natal, Western Cape, Mashonaland East Province) and updated the revision tag to v3.3.3; removed the previous 'X Locations' subheadings (e.g., 'South-East District Locations', 'Nyanza Locations').SummaryDifference0.7%

- Check74 days agoChange DetectedPublication notes updated to indicate PubMed-sourced publications are automatically filled and the page revision was updated to v3.3.2; the older version note referencing v3.2.0 was removed.SummaryDifference0.1%

- Check81 days agoChange DetectedThe government funding notice banner at the top of the page has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to Cabotegravir vs TDF/FTC in Women Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabotegravir vs TDF/FTC in Women Clinical Trial page.